Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Doctors need to be better prepared to assess and treat obesity in patients.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

SHBG may be a useful early indicator and treatment target for PCOS.

Researchers found 15 new genetic links to skin traits in Japanese women.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.